Ralf-Dieter Hilgers was nominated as IRDiRC Task Force Member

Ralf-Dieter Hilgers has been invited to serve as an IRDiRC Task Force Member to advance progress in the field of Small Population Clinical trials. With this Task Force, the International Rare Disease Consortium aims at delivering 200 new therapies for rare diseaes and at the means to diagnose most rare diseases by 2020. IDeAl has been identified as a key-player in the field of small population clinical trials, and will take part in the task force as a key-member.